Market
Intuitive’s shares fall 8% after tempering 2026 procedural growth outlook
Intuitive Surgical revised its 2026 procedural growth guidance downward to a 14–15% midpoint, from a prior range of 13.5–15.5%, triggering an 8% decline in share price. The adjustment signals softer near-term demand expectations for the robotic surgery platform amid broader market conditions.
The source
This brief is a MedIndexer summary of reporting by Medical Device Network. To read the full story, head to the source.
Read the full story at Medical Device Network